Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Receivables: 2020-2023

Historic Receivables for Revolution Medicines (RVMD) over the last 4 years, with Dec 2023 value amounting to $1.3 million.

  • Revolution Medicines' Receivables fell 73.16% to $1.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $8.1 million, marking a year-over-year decrease of 60.87%. This contributed to the annual value of $1.3 million for FY2023, which is 73.16% down from last year.
  • Per Revolution Medicines' latest filing, its Receivables stood at $1.3 million for FY2023, which was down 73.16% from $4.7 million recorded in FY2022.
  • In the past 5 years, Revolution Medicines' Receivables registered a high of $12.8 million during FY2020, and its lowest value of $1.3 million during FY2023.
  • In the last 3 years, Revolution Medicines' Receivables had a median value of $4.7 million in 2022 and averaged $4.0 million.
  • Data for Revolution Medicines' Receivables shows a maximum YoY crashed of 73.16% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Revolution Medicines' Receivables stood at $12.8 million in 2020, then slumped by 53.63% to $5.9 million in 2021, then dropped by 21.18% to $4.7 million in 2022, then slumped by 73.16% to $1.3 million in 2023.